Epithelial RNase H2 Maintains Genome Integrity and Prevents Intestinal Tumorigenesis in Mice.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
01 2019
Historique:
received: 27 02 2018
revised: 06 09 2018
accepted: 24 09 2018
pubmed: 3 10 2018
medline: 29 1 2019
entrez: 2 10 2018
Statut: ppublish

Résumé

RNase H2 is a holoenzyme, composed of 3 subunits (ribonuclease H2 subunits A, B, and C), that cleaves RNA:DNA hybrids and removes mis-incorporated ribonucleotides from genomic DNA through ribonucleotide excision repair. Ribonucleotide incorporation by eukaryotic DNA polymerases occurs during every round of genome duplication and produces the most frequent type of naturally occurring DNA lesion. We investigated whether intestinal epithelial proliferation requires RNase H2 function and whether RNase H2 activity is disrupted during intestinal carcinogenesis. We generated mice with epithelial-specific deletion of ribonuclease H2 subunit B (H2b The H2b In analyses of mice with disruption of the ribonuclease H2 subunit B gene and colorectal tumors from patients, we provide evidence that RNase H2 functions as a colorectal tumor suppressor. H2b/p53

Sections du résumé

BACKGROUND & AIMS
RNase H2 is a holoenzyme, composed of 3 subunits (ribonuclease H2 subunits A, B, and C), that cleaves RNA:DNA hybrids and removes mis-incorporated ribonucleotides from genomic DNA through ribonucleotide excision repair. Ribonucleotide incorporation by eukaryotic DNA polymerases occurs during every round of genome duplication and produces the most frequent type of naturally occurring DNA lesion. We investigated whether intestinal epithelial proliferation requires RNase H2 function and whether RNase H2 activity is disrupted during intestinal carcinogenesis.
METHODS
We generated mice with epithelial-specific deletion of ribonuclease H2 subunit B (H2b
RESULTS
The H2b
CONCLUSIONS
In analyses of mice with disruption of the ribonuclease H2 subunit B gene and colorectal tumors from patients, we provide evidence that RNase H2 functions as a colorectal tumor suppressor. H2b/p53

Identifiants

pubmed: 30273559
pii: S0016-5085(18)35077-7
doi: 10.1053/j.gastro.2018.09.047
pmc: PMC6311085
pii:
doi:

Substances chimiques

Trp53 protein, mouse 0
Tumor Suppressor Protein p53 0
Dextran Sulfate 9042-14-2
ribonuclease HII EC 3.1.26.-
Ribonuclease H EC 3.1.26.4
ribonuclease H2, mouse EC 3.1.26.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-159.e19

Subventions

Organisme : Medical Research Council
ID : MC_PC_U127580972
Pays : United Kingdom
Organisme : Medical Research Council
ID : U127580972
Pays : United Kingdom

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

Cancer Res. 2018 Oct 15;78(20):5917-5926
pubmed: 30154151
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
Cell. 2016 Sep 22;167(1):187-202.e17
pubmed: 27662089
Nat Chem Biol. 2010 Oct;6(10):774-81
pubmed: 20729855
J Biol Chem. 2017 Mar 24;292(12):4777-4788
pubmed: 28159842
Genome Med. 2018 Apr 25;10(1):33
pubmed: 29695279
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Cancer Cell. 2013 Jan 14;23(1):93-106
pubmed: 23273920
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
pubmed: 18940858
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.11
pubmed: 18428421
Acta Neuropathol. 2017 Dec;134(6):905-922
pubmed: 29030706
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D68-73
pubmed: 16381958
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):273-278
pubmed: 29976632
Nucleic Acids Res. 2013 Jan;41(Database issue):D1228-33
pubmed: 23180781
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
PLoS Genet. 2014 Jul 17;10(7):e1004511
pubmed: 25033455
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
J Biol Chem. 2011 Mar 25;286(12):10530-9
pubmed: 21177854
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nat Genet. 2009 Oct;41(10):1138-43
pubmed: 19718028
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Nature. 2018 Jul;559(7713):285-289
pubmed: 29973717
PLoS Genet. 2014 Sep 18;10(9):e1004630
pubmed: 25233079
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Exp Med. 2012 Jul 30;209(8):1419-26
pubmed: 22802351
Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50
pubmed: 20952405
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9924-9
pubmed: 12119409
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818767455
pubmed: 29642758
Science. 1990 Jan 19;247(4940):322-4
pubmed: 2296722
Science. 2011 Jun 24;332(6037):1561-4
pubmed: 21700875
PLoS One. 2013 Sep 16;8(9):e74250
pubmed: 24066126
Nature. 2017 Aug 9;548(7666):E13-E14
pubmed: 28796214
Curr Opin Genet Dev. 2014 Feb;24:52-60
pubmed: 24657537
DNA Repair (Amst). 2017 Apr;52:110-114
pubmed: 28268090
Nature. 2013 Nov 14;503(7475):272-6
pubmed: 24089213
Methods Mol Biol. 2008;426:299-318
pubmed: 18542872
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Biochem Soc Trans. 2014 Aug;42(4):717-25
pubmed: 25109948
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Cell. 2012 May 25;149(5):1008-22
pubmed: 22579044
Hum Mol Genet. 2017 Oct 15;26(20):3960-3972
pubmed: 29016854
Oncogene. 2017 Jul 6;36(27):3820-3830
pubmed: 28263976
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13249-54
pubmed: 11606779

Auteurs

Konrad Aden (K)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: k.aden@ikmb.uni-kiel.de.

Kareen Bartsch (K)

Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.

Joseph Dahl (J)

Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.

Martin A M Reijns (MAM)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.

Daniela Esser (D)

Institute for Experimental Medicine, Christian-Albrechts-University, Kiel, Germany.

Raheleh Sheibani-Tezerji (R)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Anupam Sinha (A)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Felix Wottawa (F)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Go Ito (G)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Neha Mishra (N)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Katharina Knittler (K)

Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.

Adam Burkholder (A)

Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.

Lina Welz (L)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Johan van Es (J)

Hubrecht Institute/Royal Netherlands Academy of Arts and Sciences, Princess Maxima Centre and University Medical Centre Utrecht, Utrecht, The Netherlands.

Florian Tran (F)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.

Simone Lipinski (S)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Nassim Kakavand (N)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Christine Boeger (C)

Department of Pathology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Ralph Lucius (R)

Anatomical Institute, Christian-Albrechts-University, Kiel, Germany.

Witigo von Schoenfels (W)

Department of Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.

Clemens Schafmayer (C)

Department of Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.

Lennart Lenk (L)

Department of Pediatrics, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Athena Chalaris (A)

Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.

Hans Clevers (H)

Hubrecht Institute/Royal Netherlands Academy of Arts and Sciences, Princess Maxima Centre and University Medical Centre Utrecht, Utrecht, The Netherlands.

Christoph Röcken (C)

Department of Pathology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Christoph Kaleta (C)

Institute for Experimental Medicine, Christian-Albrechts-University, Kiel, Germany.

Stefan Rose-John (S)

Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.

Stefan Schreiber (S)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.

Thomas Kunkel (T)

Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.

Björn Rabe (B)

Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.

Philip Rosenstiel (P)

Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH